EGFR gene mutations are seen in up to 40% of never smoker, compared to 1% in the smoker, while KRAS mutation is almost exclusively limited to smoker’s lung cancer (Yang et al., 2011; Sun et al., 2007; Sonobe et al., 2005; Travis et al., 2015). This evidence concerns the gene EGFR and lung cancer.